Search
Corbus Pharmaceuticals Holdings Inc
CRBPAdd to Watchlist
10.170USD
+0.430+4.41%
Close 08-07 16:00（ET）Quotes delayed by 15 min
179.11MMarket Cap
LossP/E TTM
CRBP Financials
See Corbus Pharmaceuticals Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Corbus Pharmaceuticals Holdings Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
-1.81/-1.26
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-5.90
-60.10%
Analyst Rating
STRONG BUY
2026/08/08
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its current assets were 166.95M, with a year-on-year change of 9.14.
What are the total assets of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its total assets of Corbus Pharmaceuticals Holdings Inc were 168.19M, with a year-on-year change of 7.90.
What are the total liabilities of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its total liabilities of Corbus Pharmaceuticals Holdings Inc were 20.69M, with a year-on-year change of 53.83.
What is the total equity of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its total equity of Corbus Pharmaceuticals Holdings Inc was 147.50M, with a year-on-year change of 3.56.
What is the net operating income of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its net operating income of Corbus Pharmaceuticals Holdings Inc was -85.31M, with a year-on-year change of -75.10.
What is the net investment of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its net investment of Corbus Pharmaceuticals Holdings Inc was -1.64M, with a year-on-year change of 98.65.
What is the net financing of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its net financing of Corbus Pharmaceuticals Holdings Inc was 77.43M, with a year-on-year change of -53.52.
What is the Earnings Per Share (EPS) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.90, with a year-on-year change of -60.10.
What is the net income of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its net income was -78.54M, with a year-on-year change of -95.32.
What is the Return on Equity (ROE) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -54.18, with a year-on-year change of 8.70.
What is the Return on Assets (ROA) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.47, with a year-on-year change of -10.99.
What is the operating profit of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2025 earnings report, its operating profit was -85.31M, with a year-on-year change of -75.10.